A new alpha-emitting radiopharmaceutical therapy (RPT) for advanced prostate cancer was well tolerated, with no dose-limiting ...
New alpha-emitting radiopharmaceutical therapy achieves strong responses in advanced prostate cancer
A new alpha-emitting radiopharmaceutical therapy (RPT) for advanced prostate cancer was well tolerated, with no dose-limiting ...
Dublin, Oct. (GLOBE NEWSWIRE) -- "Global Nuclear Medicine & PET Market Horizon: Market Structure, Forecasts, Competitive Dynamics, Theranostics, and AI / Workflow Monetization, 2025A-2036E" has been ...
Global Dosimetry Market size is expected to be worth around US$ 4.9 Billion by 2034 from US$ 3.1 Billion in 2024.
Although it is a small organ, its impact on the body is enormous. Timely detection and appropriate treatment allow patients ...
A French early-access program of 3,709 patients with metastatic castration-resistant prostate cancer found that ...
The new space projects were awarded funds through the CSA’s Space Technology Development Program (STDP), which supports ...
Tech Times on MSN
Insilico Medicine's AI drug posts 40% response rate in treatment-resistant mesothelioma
AI drug discovery mesothelioma: Insilico Medicine's generative AI platform Chemistry42 produced ISM6331, an oral pan-TEAD ...
Esther Chelimo’s weight plunged from 85kg to 45kg as she developed bulging eyes, a racing heartbeat and frequent diarrhoea.
The RSNA Research Seed Grant 2027, offered by the Radiological Society of North America’s Research & Education Foundation, ...
A clinical scientist at Ninewells Hospital was sacked after accessing 386 patient records 497 times without authority — a breach the health board never made public, now exposed through an employment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results